What can a patient order for back pain if they can’t take Tylenol (acetaminophen), Non-Steroidal Anti-Inflammatory Drugs (NSAIDs), or opioids?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Pharmacologic Options for Back Pain

For patients unable to take acetaminophen, NSAIDs, or opioids, muscle relaxants are the primary pharmacologic option, with cyclobenzaprine 5 mg three times daily being the most evidence-based choice for short-term relief (up to 1-2 weeks). 1, 2

First-Line Recommendation: Muscle Relaxants

Cyclobenzaprine (Preferred Agent)

  • Start with cyclobenzaprine 5 mg three times daily rather than the traditional 10 mg dose, as this provides equivalent efficacy with significantly less sedation. 3, 4
  • The 5 mg dose is nearly 5 times more likely to produce symptom improvement compared to placebo by day 14, with a number needed to treat of approximately 3. 4
  • Maximum benefit occurs within the first 3-4 days of treatment, with efficacy declining after the first week, so limit duration to 7-14 days maximum. 3, 4
  • Patients experience improvement across all pain domains: local pain, muscle spasm, range of motion, tenderness, and activities of daily living. 4

Important Caveats for Cyclobenzaprine

  • Central nervous system adverse effects are common, particularly drowsiness (dose-dependent), so warn patients about impaired driving and operating machinery. 1
  • Avoid in elderly patients due to high risk of sedation, confusion, and falls. 5
  • Use with caution in hepatic impairment; start with 5 mg and titrate slowly in mild impairment, avoid entirely in moderate-to-severe hepatic disease. 6
  • Dry mouth is the second most common side effect after drowsiness. 6, 3

Alternative Muscle Relaxants

  • Other non-benzodiazepine muscle relaxants (methocarbamol, metaxalone) can be considered if cyclobenzaprine is not tolerated, though evidence is less robust. 1
  • Avoid carisoprodol due to metabolism to meprobamate with abuse potential. 1
  • Avoid tizanidine unless spasticity is present, as it carries hepatotoxicity risk. 1

Second-Line Option: Tricyclic Antidepressants (Chronic Pain Only)

For Chronic Low Back Pain

  • Tricyclic antidepressants (amitriptyline, nortriptyline) are an option for chronic low back pain when muscle relaxants have failed or are not appropriate. 1
  • Start amitriptyline at 10-25 mg at bedtime and titrate slowly to 50-75 mg as tolerated. 7
  • Avoid in elderly patients due to excessive anticholinergic effects (dry mouth, constipation, urinary retention, confusion) and fall risk. 5
  • Sedative effects may appear before analgesic benefits, which can take up to 30 days to develop. 7

For Chronic Pain with Radiculopathy

  • Gabapentin provides small, short-term benefits for radicular pain (sciatica), though it has not been directly compared to other treatments. 1
  • This is particularly relevant if the back pain has a neuropathic component with leg radiation.

Third-Line Option: Duloxetine (Chronic Pain, Specific Populations)

  • Duloxetine 30-60 mg daily is recommended for chronic low back pain, particularly in older adults with renal impairment where other options are limited. 5
  • Start with 30 mg daily for one week, then increase to 60 mg daily if tolerated. 5
  • This SNRI has a favorable safety profile compared to tricyclic antidepressants in older adults. 5

Critical Clinical Considerations

What NOT to Use

  • Avoid benzodiazepines as muscle relaxants for back pain—they lack evidence for efficacy and carry significant risks of dependence, sedation, and falls. 1
  • Tramadol should be avoided in this scenario since it has weak opioid properties and the patient cannot take opioids. 1

Duration of Therapy

  • Limit muscle relaxants to 1-2 weeks maximum as efficacy declines after the first week and adverse effects accumulate. 1, 3
  • For chronic pain requiring longer treatment, transition to tricyclic antidepressants or duloxetine rather than continuing muscle relaxants. 1, 5

Monitoring

  • Assess for central nervous system side effects (drowsiness, dizziness, confusion) at each follow-up, particularly in the first few days. 1, 6
  • Reassess pain and function within 3-7 days; if no improvement, consider alternative diagnoses or non-pharmacologic interventions rather than escalating medications. 1, 2

Non-Pharmacologic Therapies (Essential Adjuncts)

  • Physical therapy, structured exercise, spinal manipulation, massage, and cognitive behavioral therapy should be strongly recommended alongside any medication, as they improve outcomes without medication risks. 5, 8
  • These interventions are particularly important when pharmacologic options are limited. 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Acute Inflammatory Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cyclobenzaprine and back pain: a meta-analysis.

Archives of internal medicine, 2001

Guideline

Management of Chronic Back Pain in Older Adults with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

NSAID Efficacy and Safety for Back Pain

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.